This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Vagina
CD2_BENIGN_VULVA_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D28
- Name in latin
- Neoplasma benignum vaginae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Vagina
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Vagina
- Benign neoplasm of other and unspecified female genital organs
- Benign neoplasm of other and unspecified female genital organs
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 456 | 456 | - |
| Unadjusted period prevalence (%) | 0.16 | 0.16 | - |
| Median age at first event (years) | 41.63 | 41.63 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 407
- Matched controls
- 4069
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D28.1
ICD-10 Finland
Benign neoplasm: Vagina
9986.6
323.0
271
*
22110
ICD-8 Finland
Benign neoplasm of other female genital organs, Vagina
+∞
100.2
92
*
LEB10
NOMESCO Finland
Excision of lesion of vagina
194.5
90.3
91
6
115
Kela drug reimbursment
Breast cancer
+∞
44.6
42
*
PJA12
NOMESCO Finland
Sentinel node biopsy
127.2
33.2
35
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
30.6
29
*
2211A
ICD-9 Finland
Benign neoplasm of other female genital organs, Vagina
+∞
28.5
27
*
H02AB02
ATC
dexamethasone; systemic
28.8
23.9
32
12
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
20.0
19
*
A04AA02
ATC
granisetron; systemic, transdermal
209.7
19.7
20
*
HAC20
NOMESCO Finland
Total mastectomy
209.7
19.7
20
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
18.9
18
*
L02BA01
ATC
tamoxifen; oral
198.7
18.7
19
*
L02BG04
ATC
letrozole; oral
13.5
16.9
29
23
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
16.8
16
*
22111
ICD-8 Finland
NA
+∞
16.8
16
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
16.8
16
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
15.7
15
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
15.7
15
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
29.9
15.3
20
7
LEB00
NOMESCO Finland
Biopsy of vagina
9.5
15.2
31
35
LEB20
NOMESCO Finland
Marsupialisation of vaginal cyst
+∞
14.7
14
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
14.7
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
13.6
13
*
8412
FHL
Vaginal tumor removal
144.6
13.5
14
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
11.5
11
*
L02BG03
ATC
anastrozole; oral
+∞
11.5
11
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
11.5
11
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
11.5
11
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
3.1
11.5
66
238
A03FA01
ATC
metoclopramide; systemic, rectal
2.7
11.3
85
364
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
112.8
10.5
11
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
10.5
10
*
L02BG06
ATC
exemestane; oral
+∞
10.5
10
*
HA1AA
NOMESCO Finland
X-ray mammography
4.5
10.1
35
83
N89.8
ICD-10 Finland
Other specified noninflammatory disorders of vagina
18.1
9.5
14
8
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
9.4
9
*
UKC02
NOMESCO Finland
Cystoscopy
2.9
9.0
56
213
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
51.1
8.7
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
8.7
124
713
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
16.7
8.6
13
8
130
Kela drug reimbursment
Malignant tumour
+∞
8.4
8
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
8.4
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.4
8
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
8.4
8
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
8.4
8
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
8.4
8
*
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
14.9
8.2
13
9
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
34.1
8.1
10
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.2
7.5
27
67
TQW20
NOMESCO Finland
Tatoe
81.5
7.4
8
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
7.3
7
*
X76
ICPC
Malignant neoplasm breast female
+∞
7.3
7
*
N36.1
ICD-10 Finland
Urethral diverticulum
30.6
7.2
9
*
JN4AD
NOMESCO Finland
Body CT examination
5.0
6.9
21
44
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.8
6.9
152
1011
SPAT1153
SPAT
Removal of sutures
1.9
6.9
128
804
N89.9
ICD-10 Finland
Noninflammatory disorder of vagina, unspecified
17.0
6.8
10
6
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
6.3
6
*
LCD00
NOMESCO Finland
Hysterectomy
3.0
6.2
35
125
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
250
1755
1.94
10.80
4.9
3.3
9.5
10.1
umol/l
0.87
235
1637
49
178
2.96
10.34
2.6
1.5
14.6
2.7
ug/l
0.68
33
133
100
517
2.20
10.07
5.0
4.7
35.7
33.3
%
1.46
76
331
30
108
2.90
6.45
1.3
1.3
—
—
—
0
0
342
2872
1.76
6.35
7.4
5.1
74.8
74.5
u/l
0.06
317
2648
190
1387
1.63
5.98
3.4
3.5
24.6
52.3
ng/l
0.51
120
897
121
804
1.69
5.40
2.1
1.8
—
—
—
0
0
217
1667
1.58
5.35
4.0
3.5
—
—
—
0
0
212
1645
1.54
4.85
6.0
4.4
1.2
1.2
mmol/l
0.18
180
1460
27
111
2.52
4.55
1.1
1.1
—
—
—
0
0
305
2589
1.54
4.42
5.7
4.8
532.8
4673.3
e6/l
—
6
35
18
61
3.03
4.33
1.6
1.2
—
—
—
0
0
48
260
1.95
4.18
1.5
2.1
0.2
0.2
g/l
1.06
43
245
37
184
2.10
4.07
4.9
3.5
5.2
5.2
kpa
0.25
37
174
226
1826
1.47
4.00
6.9
5.0
1.2
1.2
mmol/l
0.12
184
1565
8
11
7.38
3.87
1.5
1.2
—
—
—
0
0
8
11
7.38
3.87
1.5
1.2
—
—
—
0
0
151
1134
1.50
3.82
2.2
2.1
53.2
56.5
u/l
0.68
134
1025
8
14
5.79
3.35
1.5
1.1
—
—
—
0
0
8
14
5.79
3.35
1.5
1.1
—
—
—
0
0
283
2454
1.40
3.05
3.3
2.8
32.4
38.0
u/l
2.18
266
2270
250
2130
1.38
2.95
3.9
3.7
6.5
6.6
mmol/l
0.27
234
1951
27
137
2.03
2.86
2.3
1.8
—
—
—
0
0
413
3876
1.69
2.79
14.3
11.3
21.1
19.4
mg/l
0.43
338
2933
158
1258
1.39
2.77
2.5
2.0
2.4
2.4
mmol/l
0.62
135
1054
26
132
2.03
2.76
2.0
1.8
—
—
—
0
0
7
15
4.72
2.60
1.1
1.3
—
—
—
0
0
7
15
4.72
2.60
1.1
1.3
—
—
—
0
0
7
15
4.72
2.60
1.1
1.3
—
—
—
0
0
7
15
4.72
2.60
1.1
1.3
—
—
—
0
0
12
44
2.77
2.56
1.5
1.1
—
—
—
0
0
17
75
2.32
2.54
1.4
1.2
—
—
—
0
0
12
45
2.71
2.47
1.6
1.1
—
—
—
0
0
13
51
2.59
2.46
1.1
1.0
—
—
—
0
0
334
3028
1.39
2.44
4.7
4.3
11.1
11.7
mm/h
0.39
304
2786
12
46
2.65
2.37
1.6
1.1
—
—
—
0
0
12
47
2.60
2.29
1.6
1.1
—
—
—
0
0
12
47
2.60
2.29
1.6
1.1
—
—
—
0
0
12
47
2.60
2.29
1.6
1.1
—
—
—
0
0
8
23
3.52
2.28
1.1
1.2
—
—
—
0
0
8
23
3.52
2.28
1.1
1.2
—
—
—
0
0
8
23
3.52
2.28
1.1
1.2
—
—
—
0
0
5
9
5.60
2.22
1.2
1.4
—
—
—
0
0
111
867
1.37
2.13
1.4
1.6
0.9
0.8
mg/l
0.15
85
657
16
75
2.17
2.11
1.1
1.2
—
—
—
0
0
55
379
1.51
2.07
1.5
1.8
397.3
366.3
nmol/l
0.63
47
345
8
26
3.11
2.02
1.1
1.3
—
—
—
0
0
176
1495
1.29
1.86
3.8
3.4
35.8
36.1
g/l
0.42
159
1377
17
89
1.95
1.72
1.6
1.2
—
—
—
0
0
5
13
3.88
1.72
2.0
2.2
—
—
—
0
0
8
31
2.61
1.66
1.1
1.3
—
—
—
0
0
114
928
1.30
1.64
1.5
1.4
—
—
—
0
0
27
167
1.66
1.62
1.4
2.3
41.9
39.8
u/l
0.16
22
146
420
4036
1.51
1.61
15.7
13.0
139.7
139.8
mmol/l
0.10
410
3920
231
2062
1.24
1.53
8.5
6.5
4.1
4.1
e9/l
0.00
211
1793
420
4043
1.49
1.51
15.9
13.1
3.9
3.9
mmol/l
0.29
408
3918
21
124
1.73
1.50
1.4
1.6
—
188.6
—
0
7
204
1804
1.24
1.45
2.3
2.3
80.8
79.3
nmol/l
0.30
174
1611
57
427
1.38
1.42
17.4
22.5
1.0
1.3
inr
—
5
65
21
127
1.69
1.39
2.1
2.2
6933.6
3406.9
u/l
0.28
12
50
29
194
1.53
1.30
1.5
1.4
—
—
—
0
0
32
220
1.49
1.27
1.9
1.5
—
—
—
0
0
5
19
2.65
1.22
2.0
1.1
—
—
—
0
0
66
522
1.31
1.18
7.2
6.3
—
—
—
0
0
187
1668
1.21
1.16
2.0
2.0
101.1
99.6
pmol/l
0.11
89
782
387
3711
1.28
1.12
12.8
10.0
79.8
80.3
ml/min/173m2
0.20
319
2961
24
348
0.67
1.09
1.9
1.7
—
—
—
0
0
20
129
1.58
1.07
1.4
1.4
—
—
—
0
0
7
34
2.07
1.03
1.0
1.3
—
—
—
0
0
120
1037
1.21
1.02
5.2
4.1
0.0
0.0
estimate
0.50
42
347
7
35
2.02
1.00
1.0
1.0
—
—
—
0
0
13
76
1.73
1.00
2.2
2.5
—
—
—
0
0
19
124
1.56
0.98
1.7
1.8
—
—
—
0
0
5
23
2.19
0.98
1.0
1.3
—
—
—
0
0
5
23
2.19
0.98
2.6
2.0
—
—
—
0
0
17
109
1.58
0.95
1.3
1.3
331.0
307.9
ug/g
—
10
59
49
385
1.31
0.94
1.8
1.9
—
—
—
0
0
64
521
1.27
0.94
1.9
1.8
—
—
—
0
0
43
333
1.32
0.92
3.7
3.1
76.9
78.1
ng/l
0.04
37
295
11
63
1.76
0.91
1.0
2.3
16.6
16.4
%
—
5
30
214
1964
1.17
0.90
4.3
3.8
0.0
0.0
estimate
0.00
39
350
45
352
1.31
0.90
1.9
1.9
4.3
5.1
umol/l
0.92
39
292
6
29
2.08
0.89
1.3
1.0
—
—
—
0
0
12
71
1.71
0.89
2.0
3.7
24.6
25.8
mmol/l
0.54
12
66
11
64
1.74
0.87
1.2
1.5
—
—
—
0
0
353
3380
1.20
0.86
4.7
4.4
15.0
14.7
pmol/l
1.13
314
3107
119
1046
1.19
0.84
3.0
2.7
546.4
1053.6
ng/l
3.20
103
868
8
48
1.68
0.79
1.0
1.4
—
—
—
0
0
129
1153
1.17
0.75
2.8
2.4
26.5
28.2
u/l
0.46
123
1109
52
428
1.24
0.72
2.0
2.0
—
—
—
0
0
43
346
1.27
0.72
2.6
2.9
—
—
—
0
0
11
68
1.63
0.72
1.8
1.7
—
—
—
0
0
17
118
1.46
0.70
1.8
1.6
1.4
1.4
ug/l
0.02
12
100
25
187
1.36
0.69
1.2
1.6
—
—
—
0
0
10
61
1.65
0.69
1.1
1.4
—
—
—
0
0
9
59
1.54
0.68
1.2
1.5
—
—
—
0
0
41
331
1.26
0.68
5.7
5.7
1.9
1.6
mmol/l
0.25
30
262
24
180
1.35
0.66
7.0
6.6
0.7
0.7
%
0.01
24
180
37
297
1.27
0.64
2.1
2.3
3.7
5.3
ug/l
0.81
26
259
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
94
832
1.16
0.62
1.3
1.3
20.6
35.9
iu/ml
1.39
25
276
18
130
1.40
0.62
3.2
4.1
1.3
1.5
%
0.88
18
125
28
355
0.77
0.62
1.1
1.2
204.5
156.1
iu/ml
0.32
14
146
24
184
1.32
0.59
7.0
6.5
1.5
1.3
%
0.31
24
184
0
23
0.00
0.58
0.0
1.3
—
4.8
—
0
18
212
1993
1.12
0.56
4.4
3.8
0.0
0.0
estimate
0.50
42
345
21
160
1.33
0.54
2.8
2.7
25.8
25.6
mmol/l
0.08
21
153
33
270
1.24
0.51
3.3
3.0
4.6
4.5
pmol/l
0.05
27
236
423
4162
1.23
0.50
16.3
12.8
69.5
69.4
umol/l
0.07
423
4162
93
839
1.14
0.49
1.5
1.7
459.8
28258142.6
pmol/l
1.04
72
683
7
46
1.53
0.48
1.1
1.4
—
—
—
0
0
346
3556
0.89
0.48
13.3
12.7
38.7
39.4
%
0.62
232
2496
17
221
0.76
0.47
1.0
1.0
—
—
—
0
0
103
941
1.12
0.45
3.1
2.9
0.1
0.4
e6/l
5.35
79
713
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
8
57
1.41
0.42
1.0
1.0
—
—
—
0
0
161
1513
1.10
0.41
4.5
4.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
5
34
1.48
0.40
2.6
3.9
—
—
—
0
0
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
440
4357
1.28
0.38
21.1
17.3
131.7
132.8
g/l
1.24
435
4288
59
526
1.14
0.38
2.1
2.2
11.8
13.6
umol/l
1.27
52
477
99
913
1.11
0.37
2.3
2.1
326.8
5250.4
umol/l
3.44
85
775
29
249
1.18
0.31
1.8
1.7
—
—
—
0
0
16
196
0.81
0.30
1.4
1.5
—
—
—
0
0
20
166
1.21
0.30
1.3
1.8
—
—
—
0
0
7
55
1.28
0.30
1.1
1.1
—
—
—
0
0
7
55
1.28
0.30
1.1
1.3
—
—
—
0
0
31
355
0.86
0.29
1.8
1.7
—
—
—
0
0
31
355
0.86
0.29
1.8
1.7
—
—
—
0
0
7
56
1.25
0.29
1.1
1.1
—
—
—
0
0
8
106
0.75
0.29
1.1
1.2
3.7
3.8
mmol/l
—
8
96
63
576
1.11
0.29
3.0
2.4
0.9
1.4
e6/l
1.30
39
315
205
1973
1.07
0.28
5.8
5.2
0.0
0.0
estimate
0.50
38
340
11
85
1.30
0.28
1.5
1.5
—
—
—
0
0
257
2495
1.07
0.27
2.9
3.1
—
—
—
0
0
105
987
1.08
0.27
1.2
1.3
0.6
2.2
u/ml
2.17
27
266
8
65
1.23
0.27
1.8
1.6
—
—
—
0
0
11
139
0.79
0.27
1.6
1.7
—
—
—
0
0
190
1827
1.07
0.27
2.5
2.8
96.4
81.6
ug/l
0.78
165
1683
81
754
1.09
0.26
1.8
1.7
1060.0
1188.6
nmol/l
0.62
60
552
126
1196
1.07
0.26
1.9
2.1
92.3
145.0
u/l
5.26
118
1132
10
127
0.78
0.26
1.3
1.2
—
—
—
0
0
88
938
0.92
0.25
2.4
2.2
3.1
3.0
mg/l
0.22
70
789
391
3859
1.09
0.24
5.8
5.4
1.7
2.2
mu/l
0.81
360
3555
10
126
0.79
0.24
1.3
1.2
—
—
—
0
0
19
221
0.85
0.23
1.4
1.4
—
—
—
0
0
5
40
1.25
0.22
1.2
1.4
—
—
—
0
0
28
315
0.88
0.22
2.4
2.4
—
29.3
—
0
10
22
191
1.16
0.22
1.5
1.5
—
—
—
0
0
5
42
1.19
0.21
1.0
1.3
—
—
—
0
0
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
95.8
—
0
6
0
13
0.00
0.21
0.0
1.0
—
109.0
—
0
6
118
1127
1.06
0.21
1.7
1.6
1.4
1.3
mmol/l
0.34
103
967
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
14
0.00
0.20
0.0
2.3
—
114.4
—
0
14
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
46
424
1.09
0.19
2.2
2.3
21.2
22.8
%
0.36
39
354
6
51
1.18
0.19
1.3
1.4
189.7
378.2
pmol/l
—
6
36
78
825
0.93
0.19
1.3
1.3
3.2
14.5
u/ml
3.64
31
318
6
52
1.16
0.19
1.2
1.1
—
—
—
0
0
16
137
1.17
0.19
2.1
1.3
—
—
—
0
0
16
137
1.17
0.19
2.1
1.3
7.0
7.4
g/l
—
8
107
6
53
1.13
0.18
1.0
1.5
—
—
—
0
0
7
60
1.17
0.18
1.1
1.2
0.7
0.6
nmol/l
—
7
55
66
700
0.93
0.17
3.4
3.9
797.5
335.9
ng/l
0.50
52
505
22
195
1.13
0.17
3.1
2.6
129.4
128.0
g/l
0.09
22
189
7
62
1.13
0.17
1.4
1.4
—
—
—
0
0
422
4189
1.10
0.17
11.0
8.7
23.2
23.0
u/l
0.07
409
4011
15
129
1.17
0.17
2.1
1.3
3.2
3.0
g/l
—
7
107
95
909
1.06
0.16
5.5
4.0
1.0
1.0
kg/l
0.01
13
125
386
3822
1.06
0.16
4.4
4.0
1.2
1.2
mmol/l
0.19
350
3467
49
521
0.93
0.14
3.2
2.7
4.7
4.2
e6/l
0.10
25
259
18
160
1.13
0.14
8.7
5.7
23.6
25.3
mmol/l
2.04
18
160
10
85
1.18
0.12
1.2
2.0
174.0
164.6
%
—
10
80
397
3942
1.05
0.11
5.1
4.6
5.8
5.8
mmol/l
0.17
358
3593
12
106
1.14
0.10
1.8
1.4
—
—
—
0
0
10
114
0.87
0.09
1.3
1.2
553.6
432.4
mg/l
—
10
103
404
4062
0.95
0.09
5.3
5.0
2.8
2.8
mmol/l
0.58
368
3731
68
703
0.96
0.08
2.5
2.1
2.5
2.4
mmol/l
0.54
62
610
15
137
1.10
0.07
2.1
1.3
3.8
3.8
g/l
—
7
106
8
76
1.05
0.07
1.3
1.6
—
—
—
0
0
22
206
1.07
0.07
1.6
1.5
—
—
—
0
0
11
122
0.90
0.07
1.7
1.4
—
—
—
0
0
11
122
0.90
0.07
1.7
1.4
—
—
—
0
0
29
275
1.06
0.07
2.9
2.9
2.5
2.4
mmol/l
0.10
24
225
74
760
0.97
0.06
1.5
1.6
—
—
—
0
0
9
100
0.90
0.06
1.2
1.2
—
—
—
0
0
11
121
0.91
0.06
1.6
1.4
—
—
—
0
0
11
121
0.91
0.06
1.6
1.4
—
—
—
0
0
27
280
0.96
0.03
1.3
1.3
—
47.1
—
0
13
48
469
1.03
0.03
2.1
2.2
2.3
2.4
g/l
0.20
42
433
124
1227
1.01
0.03
3.8
2.9
7.0
6.5
mmol/l
0.49
106
1027
398
3969
1.02
0.03
5.0
4.5
1.6
1.6
mmol/l
0.04
362
3641
16
152
1.05
0.02
1.1
1.2
—
19.3
—
0
8
121
1221
0.99
0.02
4.3
3.7
5.1
5.9
mg/mmol
0.10
66
699
94
933
1.01
0.01
1.4
1.5
21.4
22.6
nmol/l
0.35
71
790
12
125
0.96
0.00
1.8
1.5
—
—
—
0
0
14
145
0.96
0.00
1.9
2.2
0.9
1.1
%
0.69
14
145
13
134
0.97
0.00
2.4
1.3
12.4
10.3
g/l
—
8
115
10
103
0.97
0.00
2.3
1.8
197.1
314.1
ug/l
—
10
91
11
113
0.97
0.00
1.0
1.1
—
—
—
0
0
18
182
0.99
0.00
1.9
1.7
—
—
—
0
0
372
3723
1.00
0.00
6.2
5.6
39.0
39.3
mmol/mol
0.35
342
3446
399
3995
0.99
0.00
5.0
4.5
4.8
4.8
mmol/l
0.52
367
3685
8
81
0.99
0.00
2.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
108.0
—
0
8
5
51
0.98
0.00
1.0
1.1
—
70.3
—
0
7
0
9
0.00
0.00
0.0
2.8
—
113.6
—
0
9
0
5
0.00
0.00
0.0
1.2
—
7.1
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
31
310
1.00
0.00
2.8
2.0
63.8
69.3
ml/min/173m2
—
10
130
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
9
90
1.00
0.00
2.4
1.4
20.8
87.1
mg/l
—
9
72
11
110
1.00
0.00
1.5
1.8
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
9
90
1.00
0.00
2.4
1.4
30.9
34.3
mg/l
—
9
73
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_VULVA_EXALLC – Benign neoplasm: Vagina
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).